CVE-2021-31868

Name: CVE-2021-31868
Creator: NVD / NIST
Published: 2021-08-19T16:15:12.293+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 5.4/10EPSS 0.47%

Last modified Jun 17, 2026

CVE-2021-31868 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. Rapid7 Nexpose version 6.6.95 and earlier allows authenticated users of the Security Console to view and edit any ticket in the legacy ticketing feature, regardless of the assignment of the ticket. This issue was resolved in version 6.6.96, released on August 4, 2021.. EPSS estimates a 0.47% chance of exploitation in the next 30 days.

Description

Rapid7 Nexpose version 6.6.95 and earlier allows authenticated users of the Security Console to view and edit any ticket in the legacy ticketing feature, regardless of the assignment of the ticket. This issue was resolved in version 6.6.96, released on August 4, 2021.

Metrics

CVSS 3.1

5.4/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N

EPSS Probability

0.47%

37.4th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Vendor	Product	Versions
Rapid7	Nexpose	< 6.6.96

References

https://docs.rapid7.com/release-notes/nexpose/20210804/Release Notes, Vendor Advisory
https://docs.rapid7.com/release-notes/nexpose/20210804/Release Notes, Vendor Advisory

Timeline

Published: Aug 19, 2021
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2021-31868?

How severe is CVE-2021-31868?

CVE-2021-31868 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.47% probability of exploitation in the next 30 days.

How do I fix CVE-2021-31868?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2021-31868?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST